Pathway enrichment in genome-wide analysis of longitudinal Alzheimer’s disease biomarker endophenotypes.

The genetic pathways that influence longitudinal heterogeneous changes in Alzheimer’s disease (AD) may provide insight into disease mechanisms and potential therapeutic targets.